Annotation Detail

Information
Associated Genes
PTEN
Associated Variants
PTEN DELETION ( ENST00000371953.8 )
PTEN DELETION ( ENST00000371953.8 )
Associated Disease
Solid Tumor
Source Database
CIViC Evidence
Description
No objective responses were observed in the PTEN deficient cohort. Four out of 6 patients with stable disease (SD) had SD or better for ≥6 cycles, 2 of which had PTEN deficient tumors. Conclusion The addition of buparlisib to high dose carboplatin and paclitaxel was not tolerable. The combination did not reveal significant clinical activity amongst a small and heterogenous group of PTEN deficient tumors.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/5957
Gene URL
https://civic.genome.wustl.edu/links/genes/41
Variant URL
https://civic.genome.wustl.edu/links/variants/214
Rating
4
Evidence Type
Predictive
Disease
Solid Tumor
Evidence Direction
Does Not Support
Drug
Carboplatin,Buparlisib,Paclitaxel
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
28281183
Drugs
Drug NameSensitivitySupported
BuparlisibSensitivityfalse
CarboplatinSensitivityfalse
PaclitaxelSensitivityfalse